ezetimibe has been researched along with Ischemic Attack, Transient in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amarenco, P; Bruckert, E; Charles, H; Giroud, M; Kim, JS; Labreuche, J; Lavallée, PC; Lee, BC; Mahagne, MH; Meseguer, E; Nighoghossian, N; Steg, PG; Vicaut, É | 1 |
| Abtan, J; Amarenco, P; Béjot, Y; Bruckert, E; Cabrejo, L; Cha, JK; Charles, H; Ducrocq, G; Giroud, M; Guidoux, C; Hobeanu, C; Kim, JS; Kim, YJ; Labreuche, J; Lapergue, B; Lavallée, PC; Lee, BC; Lee, KB; Leys, D; Mahagne, MH; Meseguer, E; Nighoghossian, N; Pico, F; Samson, Y; Sibon, I; Steg, PG; Sung, SM; Touboul, PJ; Touzé, E; Varenne, O; Vicaut, É; Yelles, N | 1 |
| Ako, J; Arai, H; Harada-Shiba, M; Hirayama, A; Nakamura, M; Nohara, A; Uno, K | 1 |
| Bang, CN; Boman, K; Dalsgaard, M; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Ray, S; Rossebø, AB; Wachtell, K | 1 |
| Acha-Salazar, O; Larrosa-Campo, D; Novo-Robledo, F; Oterino, A; Palacio, E; Revilla, M; Viadero-Cervera, R | 1 |
2 trial(s) available for ezetimibe and Ischemic Attack, Transient
| Article | Year |
|---|---|
Intracranial Hemorrhage in the TST Trial.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Coronary Artery Disease; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Intracranial Arteriosclerosis; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Secondary Prevention; Young Adult | 2022 |
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
Topics: Adult; Aged; Anticholesteremic Agents; Atherosclerosis; Brain Ischemia; Cardiovascular Diseases; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intention to Treat Analysis; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Stroke | 2020 |
3 other study(ies) available for ezetimibe and Ischemic Attack, Transient
| Article | Year |
|---|---|
Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
Topics: Acute Coronary Syndrome; Angina, Unstable; Anticholesteremic Agents; Ezetimibe; Fibric Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Incidence; Ischemic Attack, Transient; Japan; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Revascularization; Observational Studies as Topic; PCSK9 Inhibitors; Prevalence; Proprotein Convertase 9; Prospective Studies; Registries; Research Design; Risk Factors; Stroke | 2017 |
Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Comorbidity; Coronary Artery Bypass; Ezetimibe; Female; Heart Valve Prosthesis Implantation; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multicenter Studies as Topic; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Severity of Illness Index; Simvastatin; Stroke | 2014 |
[Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack].
Topics: Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Middle Aged; Retrospective Studies; Stroke | 2016 |